GYRE THERAPEUTICS, INC. financial data

Symbol
GYRE on Nasdaq
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 07 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 453% % 39%
Quick Ratio 42% %
Debt-to-equity 30% % -61%
Return On Equity 10% %
Return On Assets 8.3% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 96,333,157 shares 3%
Common Stock, Shares, Outstanding 90,890,381 shares 6%
Entity Public Float $83,300,000 USD 650%
Common Stock, Value, Issued $91,000 USD 7.1%
Weighted Average Number of Shares Outstanding, Basic 90,850,040 shares 6.1%
Weighted Average Number of Shares Outstanding, Diluted 103,971,546 shares 1.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $107,265,000 USD 2.1%
Research and Development Expense $12,595,000 USD -2.2%
Selling and Marketing Expense $58,219,000 USD 1.9%
General and Administrative Expense $19,567,000 USD -5.5%
Costs and Expenses $95,231,000 USD -47%
Operating Income (Loss) $12,034,000 USD 64%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $15,274,000 USD 94%
Income Tax Expense (Benefit) $3,459,000 USD -41%
Net Income (Loss) Attributable to Parent $11,815,000 USD 108%
Earnings Per Share, Basic 0 USD/shares 300%
Earnings Per Share, Diluted 0 USD/shares 200%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $40,402,000 USD 155%
Accounts Receivable, after Allowance for Credit Loss, Current $25,877,000 USD
Inventory, Net $8,861,000 USD 57%
Other Assets, Current $1,436,000 USD 37%
Assets, Current $98,576,000 USD 80%
Deferred Income Tax Assets, Net $6,714,000 USD 30%
Property, Plant and Equipment, Net $23,608,000 USD -3.4%
Operating Lease, Right-of-Use Asset $1,300,000 USD -34%
Other Assets, Noncurrent $5,322,000 USD 92%
Assets $159,384,000 USD 27%
Accounts Payable, Current $556,000 USD 83%
Contract with Customer, Liability, Current $58,000 USD
Liabilities, Current $15,913,000 USD 8.1%
Operating Lease, Liability, Noncurrent $539,000 USD -51%
Other Liabilities, Noncurrent $1,427,000 USD 71250%
Liabilities $21,969,000 USD -18%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,700,000 USD -80%
Retained Earnings (Accumulated Deficit) $66,703,000 USD 9.1%
Stockholders' Equity Attributable to Parent $101,920,000 USD 61%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $137,415,000 USD 40%
Liabilities and Equity $159,384,000 USD 27%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $129,000 USD -104%
Net Cash Provided by (Used in) Financing Activities $1,344,000 USD 104%
Net Cash Provided by (Used in) Investing Activities $1,967,000 USD
Common Stock, Shares Authorized 400,000,000 shares 0%
Common Stock, Shares, Issued 90,890,381 shares 6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $3,232,000 USD
Deferred Tax Assets, Valuation Allowance $65,605,000 USD 2.9%
Deferred Tax Assets, Gross $71,594,000 USD 4.3%
Operating Lease, Liability $1,165,000 USD -35%
Payments to Acquire Property, Plant, and Equipment $122,000 USD -47%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $5,898,000 USD 92%
Lessee, Operating Lease, Liability, to be Paid $1,210,000 USD -37%
Property, Plant and Equipment, Gross $30,542,000 USD 2.6%
Operating Lease, Liability, Current $626,000 USD -9.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two $300,000 USD -51%
Lessee, Operating Lease, Liability, to be Paid, Year One $661,000 USD -14%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $45,000 USD -61%
Lessee, Operating Lease, Liability, to be Paid, Year Three $279,000 USD 163%
Deferred Tax Assets, Operating Loss Carryforwards $41,714,000 USD 2.6%
Unrecognized Tax Benefits $1,883,000 USD 0%
Operating Lease, Payments $47,000 USD -66%
Additional Paid in Capital $167,134,000 USD 24%
Amortization of Intangible Assets $323,500 USD 190%
Depreciation, Depletion and Amortization $535,000 USD 29%
Deferred Tax Assets, Net of Valuation Allowance $5,619,000 USD 20%
Share-based Payment Arrangement, Expense $3,127,000 USD -56%